The seventeenth in a series of periodic roundups of drugs that have
moved from preclinical research into clinical testing via the
announcement of a Phase I trial or an application for a trial to
industry regulators.
Arena Pharmaceuticals has announced the latest results of a phase I
clinical trial that is testing a novel insomnia compound, which
could treat the 30 to 40 per cent of US adults, who complain about
some level of insomnia in the course...
A patent has been issued to Arena Pharmaceuticals for its small
molecule treatment for obesity, which targets a specific receptor,
thought to be involved in the regulation of food intake and may be
useful in pharmaceutical compositions...
Newly discovered serotonin pathways in the nervous system are
providing a path toward future pharmaceutical treatments for
depression and other disorders such as depression, anxiety, sudden
infant death syndrome, attention deficit...